NO20055002D0 - Benzol[1,2,5]tiadiazolforbindelser - Google Patents

Benzol[1,2,5]tiadiazolforbindelser

Info

Publication number
NO20055002D0
NO20055002D0 NO20055002A NO20055002A NO20055002D0 NO 20055002 D0 NO20055002 D0 NO 20055002D0 NO 20055002 A NO20055002 A NO 20055002A NO 20055002 A NO20055002 A NO 20055002A NO 20055002 D0 NO20055002 D0 NO 20055002D0
Authority
NO
Norway
Prior art keywords
thiadiazole
benzo
Prior art date
Application number
NO20055002A
Other languages
English (en)
Other versions
NO20055002L (no
Inventor
Nigel P Shankley
Brett Allison
Laura C Mcatee
Victor K Phuong
Michal H Rabinowitz
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO20055002D0 publication Critical patent/NO20055002D0/no
Publication of NO20055002L publication Critical patent/NO20055002L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/14Thiadiazoles; Hydrogenated thiadiazoles condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/101,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20055002A 2003-03-28 2005-10-27 Benzol[1,2,5]tiadiazolforbindelser NO20055002L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45863803P 2003-03-28 2003-03-28
PCT/US2004/009589 WO2005012275A2 (en) 2003-03-28 2004-03-26 Benzo [1, 2, 5] thiadiazole compounds as cck2 modulators

Publications (2)

Publication Number Publication Date
NO20055002D0 true NO20055002D0 (no) 2005-10-27
NO20055002L NO20055002L (no) 2005-12-14

Family

ID=34115280

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055002A NO20055002L (no) 2003-03-28 2005-10-27 Benzol[1,2,5]tiadiazolforbindelser

Country Status (20)

Country Link
US (2) US7241759B2 (no)
EP (1) EP1675837A2 (no)
JP (1) JP2006528241A (no)
KR (1) KR20050119666A (no)
CN (1) CN1829704A (no)
AU (1) AU2004261547A1 (no)
BR (1) BRPI0408899A (no)
CA (1) CA2520546A1 (no)
CO (1) CO5700819A2 (no)
CR (1) CR8009A (no)
EC (1) ECSP056057A (no)
IS (1) IS8042A (no)
MX (1) MXPA05010484A (no)
NO (1) NO20055002L (no)
NZ (1) NZ542491A (no)
RS (1) RS20050733A (no)
RU (1) RU2005133206A (no)
UA (1) UA82872C2 (no)
WO (1) WO2005012275A2 (no)
ZA (1) ZA200508732B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005085188A2 (en) * 2004-03-02 2005-09-15 Compass Pharmaceuticals Llc Compounds and methods for anti-tumor therapy
KR20070057252A (ko) 2004-09-24 2007-06-04 얀센 파마슈티카 엔.브이. 설폰아미드 화합물
US7599588B2 (en) * 2005-11-22 2009-10-06 Vascular Imaging Corporation Optical imaging probe connector
EP1795198A1 (en) * 2005-12-09 2007-06-13 Hubrecht Laboratorium Treatment of Barret's esophagus
WO2008124518A1 (en) * 2007-04-03 2008-10-16 Janssen Pharmaceutica N.V. Oxo-dihydroisoindole sulfonamide compounds as modulators of the cck2 receptor
EP2053052A1 (en) * 2007-10-23 2009-04-29 Laboratorios del Dr. Esteve S.A. Process for the preparation of 6-substituted imidazo[2,1-b]thiazole-5-sulfonyl halide
KR101850813B1 (ko) 2009-06-29 2018-04-20 아지오스 파마슈티컬스 아이엔씨. 치료용 화합물 및 조성물
RU2532492C1 (ru) * 2013-01-28 2014-11-10 Государственное бюджетное образовательное учреждение высшего профессионального образования "Воронежская государственная медицинская академия им. Н.Н. Бурденко" Министерства здравоохранения Российской Федерации Способ эндоскопического лечения гастродуоденальных язв
CN106163527A (zh) 2013-11-22 2016-11-23 Cl生物科技有限责任公司 用于治疗和预防骨质疏松症的胃泌素拮抗剂

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2703995B1 (fr) 1993-04-16 1995-07-21 Sanofi Elf 5-acylamino 1,2,4-thiadiazoles, leur preparation et compositions pharmaceutiques en contenant.
ATE248823T1 (de) 1996-12-10 2003-09-15 Zeria Pharm Co Ltd 1,5-benzodiazepinderivate
MXPA02000123A (es) * 1999-06-24 2002-07-02 Smithkline Beecham Corp Antagonistas de receptor depurador de macrofago.
GB0028702D0 (en) 2000-11-24 2001-01-10 Novartis Ag Organic compounds
WO2002090353A1 (en) * 2001-05-07 2002-11-14 Smithkline Beecham Corporation Sulfonamides
ITTO20020674A1 (it) 2002-07-26 2004-01-26 Rotta Research Lab Derivati antranilici ad attivita' anticolecistochininica (anti-cck-1), procedimento per la loro preparazione e loro uso farmaceutico

Also Published As

Publication number Publication date
RS20050733A (en) 2007-06-04
UA82872C2 (en) 2008-05-26
MXPA05010484A (es) 2006-03-10
IS8042A (is) 2005-09-23
CO5700819A2 (es) 2006-11-30
NZ542491A (en) 2009-04-30
AU2004261547A1 (en) 2005-02-10
WO2005012275A3 (en) 2006-05-11
KR20050119666A (ko) 2005-12-21
WO2005012275A2 (en) 2005-02-10
NO20055002L (no) 2005-12-14
EP1675837A2 (en) 2006-07-05
ZA200508732B (en) 2007-04-25
US20040224983A1 (en) 2004-11-11
CA2520546A1 (en) 2005-02-10
CN1829704A (zh) 2006-09-06
BRPI0408899A (pt) 2006-04-18
ECSP056057A (es) 2006-01-27
CR8009A (es) 2008-09-10
US7550492B2 (en) 2009-06-23
US7241759B2 (en) 2007-07-10
JP2006528241A (ja) 2006-12-14
RU2005133206A (ru) 2006-05-10
US20070276016A1 (en) 2007-11-29

Similar Documents

Publication Publication Date Title
ZA200800785B (en) Novel benzo [D] [1,3]-dioxol derivatives
CY2014041I1 (el) 2,3-διυδρο-6-νιτροϊμιδαζο 2,1 -b-οξαζολια
IS7657A (is) thíófen efnasambönd
HK1090368A1 (en) 2,3,6-trisubstituted-4-pyrimidone derivatives
DE60216115D1 (de) BENZIMIDAZO 4,5-föISOCHINOLINON-DERIVATE
ZA200606974B (en) Substituted 1,2,3,4-tetrahydrolsoquinoline derivatives
NO20055002D0 (no) Benzol[1,2,5]tiadiazolforbindelser
IL174165A0 (en) Pyrrol derivatives with antibacterial activity
DE60214428D1 (de) 1, 4-dihydro-1, 4-diphenylpyridin-derivate
IL166202A0 (en) Azolidinone-vinyl benzene derivatives
DE60136530D1 (de) 2,4-disubstituierte thiazolyl derivate
ATE478870T1 (de) Spiroindolinpiperidinderivate
DK1556385T3 (da) Heterocyclocarboxamid-derivater
DE60330372D1 (de) Indol-3-schwefelderivate
ATE467631T1 (de) Chinuclidinamidderivate
PT1177185E (pt) Derivados de 4, 5, 6, 7-tetra-hidroindazole como agentes antitumorais
DK1474408T3 (da) N-Phenyl-2-pyrimidinaminderivater
IS2656B (is) Nýjar besímídasólafleiður
ATE396724T1 (de) 1h-thieno 2,3-c-pyrazol-derivate als kinase-i- hemmer
DE602004021572D1 (de) SUBSTITUIERTE 8-PERFLUORO-6,7,8,9-TETRAHYDROPYRIMIDOi1,2-A PYRIMIDIN-4-ON-DERIVATE
DE60307512D1 (de) 3h-chinazoline -4-on derivaten
DE602004023380D1 (de) Humor-aufsaugender gegenstand
DE602004024386D1 (de) Schwefelhaltige naphthoylimidderivate
ATE423771T1 (de) Tetrahydrochinolinderivate
DE602004010385D1 (de) 3,4-disubstituierte 1,2,3,4-tetrahydropyridinderivate

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application